All In Biotech

Drug Trial Radar · NCT06079671

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-centre, Global Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer Who Have Not Progressed Following Platinum-based, Concurrent Chemoradiation Therapy (eVOLVE-Cervical)

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

800

Planned (sponsor's estimate)

Start

Sep 22, 2023

Primary completion

Nov 26, 2027

Study completion Sep 30, 2030

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
Collaborators
Gynecologic Oncology Group Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT)
First posted
Oct 12, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with high-risk LACC (FIGO 2018 stage IIIA to IVA cervical cancer) who have not progressed following platinum-based CCRT.

Conditions

  • Locally Advanced Cervical Cancer

Interventions

  • VolrustomigBiological

    IV Infusion

  • PlaceboOther

    IV Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free Survival (PFS) based on the investigator assessment in all randomized participants (FAS)Time frame: Up to approximately 7 years

Locations

205 sites in 19 countries. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama · Withdrawn

  • Research Site

    Phoenix, Arizona · Withdrawn

  • Research Site

    Tucson, Arizona · Withdrawn

  • Research Site

    Little Rock, Arkansas · Withdrawn

  • Research Site

    La Jolla, California · Withdrawn

  • Research Site

    West Hollywood, California · Withdrawn

  • Research Site

    Atlanta, Georgia · Withdrawn

  • Research Site

    Augusta, Georgia · Withdrawn

  • Research Site

    Savannah, Georgia · Terminated

  • Research Site

    Melrose Park, Illinois · Withdrawn

  • Research Site

    Indianapolis, Indiana · Withdrawn

  • Research Site

    New Orleans, Louisiana · Withdrawn

  • Research Site

    New Orleans, Louisiana · Withdrawn

  • Research Site

    Shreveport, Louisiana · Completed

  • Research Site

    New York, New York · Withdrawn

  • Research Site

    Syracuse, New York · Withdrawn

  • Research Site

    Cleveland, Ohio · Withdrawn

  • Research Site

    Columbus, Ohio · Withdrawn

  • Research Site

    Eugene, Oregon · Withdrawn

  • Research Site

    Philadelphia, Pennsylvania · Withdrawn

  • Research Site

    Providence, Rhode Island · Withdrawn

  • Research Site

    Dallas, Texas · Withdrawn

  • Research Site

    Fort Worth, Texas · Terminated

  • Research Site

    Houston, Texas · Withdrawn

  • Research Site

    Tyler, Texas · Withdrawn

  • Research Site

    Charlottesville, Virginia · Completed

  • Research Site

    Fairfax, Virginia · Withdrawn

  • Research Site

    Richmond, Virginia · Withdrawn

  • Research Site

    Barretos, Brazil · Recruiting

  • Research Site

    Belo Horizonte, Brazil · Recruiting

  • Research Site

    Curitiba, Brazil · Recruiting

  • Research Site

    Fortaleza, Brazil · Recruiting

  • Research Site

    Fortaleza, Brazil · Recruiting

  • Research Site

    Goiânia, Brazil · Not yet recruiting

  • Research Site

    Ijuí, Brazil · Recruiting

  • Research Site

    Natal, Brazil · Recruiting

  • Research Site

    Porto Alegre, Brazil · Recruiting

  • Research Site

    Porto Alegre, Brazil · Recruiting

  • Research Site

    Porto Alegre, Brazil · Recruiting

  • Research Site

    Porto Velho, Brazil · Recruiting

Showing 40 of 205 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.